Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001628280-25-004088

Chief Financial Officer gave up 6,544 shares (to pay taxes)

  • Chief Financial Officer acquired 48,940 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Taylor Ben R · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-03 Grant or award : show line 1 in the form +35,018 879,228 D
2025-02-03 Grant or award : show line 2 in the form +13,922 893,150 D
2025-02-03 Shares withheld for taxes : show line 3 in the form −6,544 $7.25 $47,444 886,606 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-03 Grant or award : show line 4 in the form Stock Option (Right to Buy) +70,037 70,037 D
Loading xslF345X05/wk-form4_1738792233.xml…